Effect of dual residual risk of cholesterol and inflammation on all-cause mortality in patients with cardiovascular disease

BACKGROUND: Randomized controlled trials confirm that risks of residual cholesterol and residual inflammation remains in patients with cardiovascular disease (CVD) even after lipid-lowering therapy. This study aims to investigate the association between dual residual risk of cholesterol and inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ling, Yue, Qing, Fang, Fang, Zhang, Yinggen, Liu, Peipei, Zhang, Zihao, Wang, Guodong, Chen, Shuohua, Wu, Shouling, Yang, Xiuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127069/
https://www.ncbi.nlm.nih.gov/pubmed/37095492
http://dx.doi.org/10.1186/s12933-023-01826-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127069/
https://www.ncbi.nlm.nih.gov/pubmed/37095492
http://dx.doi.org/10.1186/s12933-023-01826-3

Ejemplares similares